Literature DB >> 12183308

Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study.

Annelies Wilder-Smith1, Timothy M S Barkham, Arul Earnest, Nicholas I Paton.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12183308      PMCID： PMC117886          DOI： 10.1136/bmj.325.7360.365

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Serogroup W135 meningococcal disease in Hajj pilgrims.

Authors:  M K Taha; M Achtman; J M Alonso; B Greenwood; M Ramsay; A Fox; S Gray; E Kaczmarski
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Meningococcal disease, serogroup W135.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-05-11

Review 3.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Authors:  T Popovic; C T Sacchi; M W Reeves; A M Whitney; L W Mayer; C A Noble; G W Ajello; F Mostashari; N Bendana; J Lingappa; R Hajjeh; N E Rosenstein
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883
  4 in total
  13 in total

1.  Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.

Authors:  Amanda J Beddek; Ming-Shi Li; J Simon Kroll; T William Jordan; Diana R Martin
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

2.  Total antioxidant capacity of plasma in asymptomatic carrier state of Neisseria meningitidis.

Authors:  J Uberos; A Molina-Carballo; G Galdo-Muñoz; A Muñoz-Hoyos
Journal:  Epidemiol Infect       Date:  2006-11-17       Impact factor: 2.451

Review 3.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.

Authors:  Luciana M Hollanda; Gisele Cg Cury; Rafaella Fc Pereira; Gracielle A Ferreira; Andreza Sousa; Edesia Mb Sousa; Marcelo Lancellotti
Journal:  J Nanobiotechnology       Date:  2011-07-25       Impact factor: 10.435

5.  Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process.

Authors:  Ives B Mattos; Danilo A Alves; Luciana M Hollanda; Helder J Ceragiogli; Vitor Baranauskas; Marcelo Lancellotti
Journal:  J Nanobiotechnology       Date:  2011-11-16       Impact factor: 10.435

6.  Health risks among travelers to Brazil: implications for the 2014 FIFA World Cup and 2016 Olympic Games.

Authors:  Mary Elizabeth Wilson; Lin H Chen
Journal:  Travel Med Infect Dis       Date:  2014-04-18       Impact factor: 6.211

Review 7.  Expected immunizations and health protection for Hajj and Umrah 2018 -An overview.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2017-10-14       Impact factor: 6.211

8.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

9.  Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Suok Kai Chew; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  Serogroup W135 meningococcal disease, The Gambia, 2012.

Authors:  M Jahangir Hossain; Anna Roca; Grant A Mackenzie; Momodou Jasseh; Mohammad Ilias Hossain; Shah Muhammad; Manjang Ahmed; Osuorah Donatus Chidiebere; Ndiaye Malick; S M Bilquees; Usman N Ikumapayi; Baba Jeng; Baba Njie; Mamady Cham; Beate Kampmann; Tumani Corrah; Stephen Howie; Umberto D'Alessandro
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.